These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34565273)

  • 1. Improved anticancer activity of betulinic acid on breast cancer through a grafted copolymer-based micelles system.
    Qi X; Gao C; Yin C; Fan J; Wu X; Guo C
    Drug Deliv; 2021 Dec; 28(1):1962-1971. PubMed ID: 34565273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of quercetin-loaded PVCL-PVA-PEG micelles and application in inhibiting tumor angiogenesis through the PI3K/Akt/VEGF pathway.
    Qi X; Gao C; Yin C; Fan J; Wu X; Di G; Wang J; Guo C
    Toxicol Appl Pharmacol; 2022 Feb; 437():115889. PubMed ID: 35065992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
    Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
    Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of a novel drug delivery: Soluplus
    Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glucose-targeted mixed micellar formulation outperforms Genexol in breast cancer cells.
    Moretton MA; Bernabeu E; Grotz E; Gonzalez L; Zubillaga M; Chiappetta DA
    Eur J Pharm Biopharm; 2017 May; 114():305-316. PubMed ID: 28192249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluplus(®) micelles as a potential drug delivery system for reversal of resistant tumor.
    Jin X; Zhou B; Xue L; San W
    Biomed Pharmacother; 2015 Feb; 69():388-95. PubMed ID: 25661387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy.
    Zhao J; Xu Y; Wang C; Ding Y; Chen M; Wang Y; Peng J; Li L; Lv L
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1197-1204. PubMed ID: 28300426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of self-assembly Soluplus
    Jiang S; Mou Y; He H; Yang D; Qin L; Zhang F; Zhang P
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1788-1798. PubMed ID: 31500443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment.
    Sun F; Zheng Z; Lan J; Li X; Li M; Song K; Wu X
    Drug Deliv; 2019 Dec; 26(1):575-585. PubMed ID: 31172843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells.
    Shin J; Lee HJ; Jung DB; Jung JH; Lee HJ; Lee EO; Lee SG; Shim BS; Choi SH; Ko SG; Ahn KS; Jeong SJ; Kim SH
    PLoS One; 2011; 6(6):e21492. PubMed ID: 21731766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system.
    Hou J; Sun E; Sun C; Wang J; Yang L; Jia XB; Zhang ZH
    Int J Pharm; 2016 Oct; 512(1):186-193. PubMed ID: 27567930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermosensitive Betulinic Acid-Loaded Magnetoliposomes: A Promising Antitumor Potential for Highly Aggressive Human Breast Adenocarcinoma Cells Under Hyperthermic Conditions.
    Farcas CG; Dehelean C; Pinzaru IA; Mioc M; Socoliuc V; Moaca EA; Avram S; Ghiulai R; Coricovac D; Pavel I; Alla PK; Cretu OM; Soica C; Loghin F
    Int J Nanomedicine; 2020; 15():8175-8200. PubMed ID: 33122905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acid.
    Yu M; Ocando JE; Trombetta L; Chatterjee P
    AAPS PharmSciTech; 2015 Apr; 16(2):384-97. PubMed ID: 25331193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach.
    Pereira-Silva M; Diaz-Gomez L; Blanco-Fernandez B; Ferreirós A; Veiga F; Concheiro A; Paiva-Santos AC; Alvarez-Lorenzo C
    Int J Pharm; 2024 Sep; 662():124529. PubMed ID: 39084580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
    Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
    Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and antitumor evaluation of hinokiflavone hybrid micelles with mitochondria targeted for lung adenocarcinoma treatment.
    Chen Y; Feng X; Li L; Song K; Zhang L
    Drug Deliv; 2020 Dec; 27(1):565-574. PubMed ID: 32252563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved bioavailability and anticancer efficacy of Hesperetin on breast cancer via a self-assembled rebaudioside A nanomicelles system.
    Wang J; Li Q; Chen Z; Qi X; Wu X; Di G; Fan J; Guo C
    Toxicol Appl Pharmacol; 2021 May; 419():115511. PubMed ID: 33819459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol micelles for docetaxel delivery in breast cancer: an in vitro study on two cell lines of breast cancer.
    Varshosaz J; Dehkordi AJ; Setayesh S
    Pharm Dev Technol; 2017 Aug; 22(5):659-668. PubMed ID: 27268258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of the antitumor activity of poorly soluble sapacitabine (CS-682) by using Soluplus® as a surfactant.
    Obata T; Suzuki Y; Ogawa N; Kurimoto I; Yamamoto H; Furuno T; Sasaki T; Tanaka M
    Biol Pharm Bull; 2014; 37(5):802-7. PubMed ID: 24790002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.